Annexon (ANNX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Annexon (ANNX) is Neutral.

The composite score behind that read is -0.10, weighing +0.23 of bullish evidence against -0.23 bearish.

Annexon last closed at $4.02, +0.50% on the session.

Against the IVW growth benchmark the position is -0.30% over the forecast window.

The read is built from 15 underlying insights — 1 bullish and 14 bearish.

Agreement across those insights is 93%.

13 graded predictions for ANNX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Annexon in the 10th percentile on return on equity, where 100 is best.

Annexon is classified under Health Care / Biotechnology, with a market capitalisation of $758.32M.

StockMap tracks Annexon as the 148th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Annexon ranks 213th of 381 in the group, against a group median of -0.08.